CAIR LGL
Alexandre Lopez has a diverse work experience. Alexandre began their career as a research assistant at McGill University in 2013. In 2014, they completed an internship at the University of Cambridge. From 2015 to 2019, they worked as a PhD student at INSERM U935, focusing on chronotherapy of cancers and liver function optimization. In 2019, they joined Institut Georges Lopez (IGL) as the Director of Research and Development and later became the Chief Executive Officer in 2021. In 2023, they will assume the position of Chief Executive Officer at CAIR LGL.
Alexandre Lopez completed their education from Université Paris-Saclay as they earned a Doctor of Philosophy (PhD) degree in Biologie cellulaire et anatomie from 2015 to 2019. Prior to that, they pursued a Master's degree in Génétique, Biollogie Cellulaire et Pathologies from Université Claude Bernard Lyon 1 from 2012 to 2014. Alexandre's educational journey started with a Bachelor's degree in Sciences, Technologies et Santé from the same university, which they completed from 2010 to 2012.
This person is not in any teams
CAIR LGL
Cair LGL is an international affiliate of the CAIR Group specialized in the medical sector. CAIR LGL is a major player in the field of medical devices. It designs, produces and distributes complete ranges of secure and innovative products for hospitals and healthcare professionals. Since 1987, the company has grown rapidly, gaining a strong position on the French and international markets, with the support of its subsidiaries and distributors in more than 60 countries. Cair LGL, a company on a human scale, is made up of men and women recognized for their know-how and expertise, who are passionately committed to improving the quality and safety of patient care. Joining Cair LGL means being part of a corporate project, committed to meeting the needs of patients and healthcare professionals.